16-18
Jun
2026
CPHI & PMEC China 2026
Shanghai New International Expo Center
E3A42
8-10
Jul
2026
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
S51
25-27
Aug
2026
CPHI Korea 2026
COEX, Seoul, Korea
ED09
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
14C12

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.

About Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.

A leading High-end Pharmaceutical Injectables manufacturer from China with over 60 ANDAs approved in USA. Top 3 supplier of Heparin and Enoxaparin APIs across the globe. 
Top exporter from China to US of Injetables with over 250 Million USD revenue per year.
Two manufacturing sites for Injectables and one API manufacturing site accrediated with USFDA,  EMA, PMDA. 

Certifications

Meet us at

  • CPHI & PMEC China 2026

    Shanghai New International Expo Center
    16 Jun 2026 - 18 Jun 2026
  • CPHI South East Asia 2026

    QSNCC, Bangkok, Thailand
    08 Jul 2026 - 10 Jul 2026
  • CPHI Korea 2026

    COEX, Seoul, Korea
    25 Aug 2026 - 27 Aug 2026
  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Biopharmaceutical
Pharmaceutical Company (generic finished products)
Contact info
  • 16 Xuefu Road,High&New Tech Development Zone, 21006, Nanjing, J.S., China

Products from Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (1)

  • Heparin Sodium/ Enoxaparin Sodium

    Product Heparin Sodium/ Enoxaparin Sodium

    API and FDF both Approved in US, EU, China, Brazil US GMP, EU GMP, Japan GMP, China GMP, Brazil GMP, Mexico GMP available. World’s most stable supply, best quality, competitive price.